The programme has already drawn over 120 complex percutaneous coronary intervention (PCI) case submissions from across the country
Spread across 7,000 square feet, the Bengaluru facility is positioned as a purpose-built clinical prevention centre focused on identifying silent, life-threatening diseases in asymptomatic individuals
The approved product is a generic version of Ravicti, originally developed and marketed by Horizon Therapeutics
In his new role, Curtis will lead the formulation and execution of the company’s global technical strategy
Bajaj joins Health Prime after a long and progressive tenure at Concentrix
PMDA is regarded among the most stringent regulatory bodies globally
The investment will support the company’s plans to expand its network of specialised surgical hospitals across India.
The long-term exposure to fine particulate matter (PM2.5) increases overall cancer risk by 11%
Subscribe To Our Newsletter & Stay Updated
